Results 181 to 190 of about 36,270 (220)

A platform for glycoengineering a polyvalent pneumococcal bioconjugate vaccine using E. coli as a host [PDF]

, 2019
Chavez, Sthefany M., Feldman, Mario F., Huynh, Jeremy P., Kinsella, Rachel L., Mayer, Anne E., Stallings, Christina L.   +5 more
core   +1 more source

Correction to: Radiographically confirmed pneumonia in Malawian children and associated Pneumococcal carriage after introduction of the 13-valent Pneumococcal conjugate vaccine. [PDF]

Pneumonia (Nathan)
Mzumara G, Chirombo J, D Swarthout T, Bar-Zeev N, Prisca Harawa P, Sanusi Jalloh M, Kirolos A, Mukhula V, Newberry L, Ogunlade O, Wachepa R, French N, S Heyderman R, Iroh Tam PY.   +13 more
europepmc   +1 more source

Long-term impact of 10-valent pneumococcal conjugate vaccine among children <5 years, Uganda, 2014-2021. [PDF]

PLOS Glob Public Health
Wanyana MW, Migisha R, King P, Bulage L, Kwesiga B, Kadobera D, Ario AR, Harris JR.   +7 more
europepmc   +1 more source

Cost-effectiveness analysis of the 13-valent pneumococcal conjugate vaccine administered to children under 5 years of age in the Republic of Moldova. [PDF]

Med Pharm Rep
Balanuta AM, Bujor D, Paraschiv A, Horodisteanu-Banuh A, Revenco N.   +4 more
europepmc   +1 more source

Cost-Effectiveness and Public Health Impact of 24-Valent Pneumococcal Conjugate Vaccine Compared With the Recommended Pneumococcal Vaccines in Older Adults. [PDF]

Am J Prev Med
Smith KJ, Wateska AR, Nowalk MP, Lin CJ, Harrison LH, Schaffner W, Zimmerman RK.   +6 more
europepmc   +1 more source

Emergence of non-vaccine Streptococcus pneumoniae serotypes colonizing the nasopharynx of children under five years of age in the 13-valent pneumococcal conjugate vaccine era in Tanzania. A short communication. [PDF]

Vaccine
Ngocho JS, van der Gaast-de Jongh CE, Sebba J, Mtei M, Kinabo G, Mmbaga BT, de Jonge MI.   +6 more
europepmc   +1 more source